Suzhou Shengsu New Drug Development Co.

Company profile

Suzhou Shengsu New Drug Development Co. company profile

3D BioOptima specializes in providing comprehensive solutions and services for drug development projects. The company focuses on metabolic stability studies of compounds in liver microsomes, offering a range of services including pharmacokinetic (PK) studies for both small and large molecules, exploratory toxicity studies in rodents and non-rodents, and mechanistic in-vivo ADME studies. 3D BioOptima utilizes a 3D culture system to better understand pharmacological mechanisms and efficacies on human tumor cells, aiming to support oncology drug discovery. With a commitment to delivering optimized solutions and value-added services, 3D BioOptima has successfully completed over 100 IND-enabling studies over the past six years,..... For more information, log in to dureach.com to view the full company profile.